Target intelligence / Profile preview

Elephant endotheliotropic herpesvirus 1A glycoprotein H (EEHV1A gH)

Target
EEHV1A gH
Molecular classification
Viral envelope glycoprotein, Fusion protein
01

Overview

Elephant endotheliotropic herpesvirus 1A glycoprotein H (gH) is a conserved viral envelope protein encoded by the ORF22 gene, playing a fundamental role in the infection process of Asian elephants (Elephas maximus) (Wilkie et al., 2014). It typically functions as a heterodimer with glycoprotein L (gL), forming the gH/gL complex which is indispensable for mediating the fusion between the viral envelope and the host cell membrane (Long et al., 2016). This fusion event is a prerequisite for the delivery of the viral genome into the host cell, specifically targeting endothelial cells, which leads to the devastating Elephant Endotheliotropic Herpesvirus Hemorrhagic Disease (EEHV-HD) (Fuery et al., 2020). Given its essential role in viral entry and its exposure on the virion surface, gH is a primary target for neutralizing antibodies and is currently a leading candidate for subunit and mRNA vaccine development (Heaggans et al., 2020). While traditional treatments for EEHV-HD involve nucleoside analogs like famciclovir that inhibit DNA polymerase, targeting gH offers a strategy to block the initial stages of infection and reduce viral dissemination (Stanton et al., 2013). The structural complexity of the gH/gL complex presents challenges for protein expression and vaccine formulation, yet it remains a critical focus for conservation efforts (Gunaryo et al., 2023). Research into monoclonal antibodies targeting gH is also underway to provide passive immunity for acutely ill calves (Long et al., 2016).

Other names
gHORF22Glycoprotein H
02

Mechanism of action

Neutralization of viral entry by blocking gH/gL-mediated membrane fusion

03

Biological functions

Viral entryMembrane fusionHost cell attachment
04

Disease associations

InfectionElephant endotheliotropic herpesvirus hemorrhagic disease
05

Safety considerations

Antibody-dependent enhancement (ADE)Strain-specific variability (EEHV1A vs 1B)Immune evasionLogistical challenges in wildlife administration
06

Biomarkers

EEHV1A DNA load (qPCR)Anti-gH antibody titers (IgG/IgM)

Beyond the preview

Go deeper on Elephant endotheliotropic herpesvirus 1A glycoprotein H (EEHV1A gH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elephant endotheliotropic herpesvirus 1A glycoprotein H (EEHV1A gH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call